In this study, we also found that combination therapy of NOX4 inhibitor (GKT137831) and afatinib decreased cell viability and had a synergy effect in ovarian cancer cells, which might be a strategy for ovarian cancer treatment. This evidence concerns the gene NOX4 and ovarian carcinoma.